Academic Journal
Main Category: Diabetes
Also Included In: Obesity / Weight Loss / Fitness
Article Date: 29 Jul 2013 - 5:00 PDT Current ratings for:
Gastric bypass offers clues to solving diabetes
Scientists have discovered why a gastric bypass can help cure type 2 diabetes, according to a study published in the journal Science.
Researchers from Boston Children's Hospital reveal that the small intestine, which they had thought to be a passive organ, is actually a major contributor to the body's metabolism.
The researchers say that previous research has already shown that gastric bypass surgery can help resolve type 2 diabetes. However, they add that until now, the reason for this has been unclear.
The research team studied the after-effects of gastric bypass surgery in rats over a year and analyzed the way the small intestine processed glucose.
The researchers found that the small intestine uses and disposes of glucose. This regulates blood glucose levels which then helps to resolve type 2 diabetes.
Nicholas Stylopoulos of the division of endocrinology at the hospital, says:
"We have seen type 2 diabetes resolve in humans after gastric bypass, but have never known why. People have been focusing on hormones, fat and muscle, but we have shown in this study that the answer lies somewhere in the small intestine most of the time."
Gastric bypass surgery is a weight-loss treatment usually reserved for severely obese individuals. It works by redirecting the food into a smaller pouch in the stomach, bypassing the stomach and duodenum - the first section of the small intestine.
The researchers discovered that following gastric bypass surgery, the small intestine "reprograms" itself to produce GLUT-1, which is not usually present before surgery.
GLUT-1 usually works as a "transporter," responsible for removing glucose from the circulation and using it within the intestine.
However, the scientists discovered that after surgery, GLUT-1 takes glucose from the circulation and disposes of it, leading to stabilized glucose levels in the rest of the body.
The researchers say that of the rats analyzed after gastric bypass surgery, 100% had been cured of type 2 diabetes. They add that 64% of the diabetes had been cured by the gut surgery alone, while the other 36% could be a result of weight loss or other factors.
Nicholas Stylopoulos says this research could lead to investigating ways of "mimicking" the intestine's programming without the need for surgery: "Previously, we had not considered the intestine as a major glucose-utilizing organ. We have found this process is exactly what happens after surgery." Stylopoulos added:
With further research, we may find ways to bypass the bypass.
The results of our study are promising because, unlike the brain and other organs, intestines are easily accessible.
Furthermore, since cells in the intestine have such a short lifespan, we can easily study and pharmacologically manipulate them to use glucose, without long-term problems."
Previous research has suggested that although gastric bypass surgery helps diabetic symptoms disappear for some patients, it is not a long-term cure.
Scientists from the Group Health Research Institute carried out a study revealing that in 4,434 patients who had gastric bypass surgery, their symptoms of type 2 diabetes returned within five years of the operation.
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our diabetes section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:
MLA
29 Jul. 2013.
Please note: If no author information is provided, the source is cited instead.
posted by ralphla54 on 29 Jul 2013 at 7:50 am
A new FDA approved diet pill called Belviq just went on the market. Belviq make people more likely to succeed with weight loss since they feel full more quickly and it reduces food cravings. People who take Belviq with diet and exercise were 2 times more likely to lose 5% body weight and 3 times more likely to lose 10% body weight than the people who just did diet and exercise alone. The label states that if you do not lose 5% of your body weight in 12 weeks then consider stopping. Those that do respond in 12 (about 45% of patients) weeks go on to lose over 10% of their body weight in one year. Losing 22 pounds for a 220 pound person is life changing. So 45% of those taking Belviq lose significant amount of weight.
Belviq has a second mode of action to reduce blood sugar which may end up preventing diabetes in many cases. Diabetics and pre-diabetics who took Belviq, REGARDLESS of weight loss, saw their blood sugar numbers drop by double digit percentages. IE HbA1c -0.9 to -1.2 and fasting glucose feel -27. The cost of medications to reduce HbA1c levels exceeds the cost of Belviq. (see Arena's BloomDM phase III trial http://clinicaltrials.gov/ct2/show/NCT00603291 ) These reductions in diabetic symptoms plus the weight loss at the same time makes Belviq a medical bargain: http://www.belviq.com/ .
| post followup | alert a moderator |
'Gastric bypass offers clues to solving diabetes'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
No comments:
Post a Comment